sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Asciminib

Medicine

Asciminib

SCEMBLIX is indicated for the treatment of adult patients with: Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
  • Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). This indication is approved under accelerated approval based on major molecular response rate. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).
  • Previously treated Ph+ CML in CP.
  • Ph+ CML in CP with the T315I mutation.

What it is used for

SCEMBLIX is indicated for the treatment of adult patients with:

  • Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). This indication is approved under accelerated approval based on major molecular response rate. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).
  • Previously treated Ph+ CML in CP.
  • Ph+ CML in CP with the T315I mutation.

Side effects, and when to stop

The following clinically significant adverse reactions can occur with SCEMBLIX and are discussed in greater detail in other sections of the labeling:

  • Myelosuppression
  • Pancreatic Toxicity
  • Hypertension
  • Hypersensitivity
  • Cardiovascular Toxicity

Who should not take it

None.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Asciminib; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/asciminib

APA 7th

sofidex. (2026, August 2). Asciminib. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/asciminib

AMA 11th

Asciminib. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/asciminib

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.